Navigation Links
An alternative vaccine to combat Anthrax

A vaccine researcher at the Saint Louis University published his findings on a better substitute to the currently available anthrax vaccine, this month//.

According to peer-reviewed research published in Vaccine this new vaccine could elicit the kind of immune response doctors were looking for.

In its first human testing, the vaccine was given to 100 volunteers at four sites around the United States, said Geoffrey Gorse, M.D., a Saint Louis University researcher who was the main author of the paper.

"This type of research, five years after 9/11, continues to be very important to pursue," Gorse said. "We need a better vaccine to help protect people from anthrax infection, whether the vaccine is given before or soon after exposure to anthrax spores."

Gorse said the study was able to answer some important questions about this candidate vaccine.

"We were able to demonstrate in this study that the investigational anthrax vaccine produced an immune response that justifies further testing in larger studies," he said. "We'll be using this data to help design strategies for testing of this vaccine in the future."

Gorse indicated that the investigational vaccine, made by VaxGen Inc., demonstrated a clear relationship between the amount of vaccine administered and the subsequent immune response.

The study was designed to evaluate the safety and immunogenicity of escalating doses of the new vaccine. A total of 100 healthy adults were randomized to receive either one of four different vaccine formulations, or AVA, the anthrax vaccine currently licensed for use in the United States. All vaccinations were administered intramuscularly. Source: Eurekalert
'"/>




Page: 1

Related medicine news :

1. Record growth of Soya-based dairy alternatives in Europe
2. Sperm stem cells could be an alternative to embryonic stem cells in future
3. Vioxx and Celebrex, now have alternatives
4. Alternative therapy – an alternative to HRT
5. New hope for cancer victims – will vaccine cure the deadly bug
6. New vaccine helps allergy and asthma patients
7. Man against HIV – new vaccine ready for human trials
8. New vaccine helps allergy and asthma patients
9. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
10. HIV did not arise from polio vaccine
11. Double impact vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... ... Digital Scientists, a software innovation lab specializing in web design and ... Carolina location. The lab has set up shop at the renowned NEXT Innovation ... Carolina clients for years from our office here in Atlanta,” explains Digital Scientists’ CEO, ...
(Date:3/24/2017)... Lake Orion, MI (PRWEB) , ... March 24, ... ... providing insurance assistance, financial planning, and related services to families and business owners ... charity initiative aimed at feeding regional families struggling with financial difficulties. , The ...
(Date:3/24/2017)... CA (PRWEB) , ... March 24, 2017 , ... ... on two panels at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, ... Creating the Administrative Record, The majority of cases litigated under ERISA involve claims ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... first Certified Medical Reiki™ Master in Frederick, MD. Judy says, “I am passionate ... during what is often a very difficult and challenging time.” , A Certified ...
(Date:3/24/2017)... ... ... Adventures of Joey, The Dog Who Barks at Puddles”: a boisterous story about a ... God intended. “The Adventures of Joey, The Dog Who Barks at Puddles” is the ... writing, especially about truth and human behavior. , Published by Christian Faith Publishing, Patti ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Tenn. , March 23, 2017  Provectus ... or the "Company"), a clinical-stage oncology and dermatology ... announced Definitive Financing Commitment Term Sheet (the "Definitive ... a group of the Company,s stockholders, who are ... Group" in a Form 8-K filed with the ...
(Date:3/23/2017)... 23, 2017 The key factors driving ... diabetic population, accelerating economic growth and increasing healthcare expenditure. Some ... higher life expectancy of ESRD patients, rising demand for home ... the expansion of the market is hindered by high treatment ... ...
(Date:3/23/2017)... 23, 2017 As a result of ... the prevalence of allergic diseases, cutting edge developments ... revolutionising the ways in which pharmaceutical and biotech ... promises to be both a high quality meeting ... interest groups, immunologists, research scholars and doctors. The ...
Breaking Medicine Technology: